EORTC
@EORTC
Followers
16K
Following
3K
Media
1K
Statuses
4K
European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life
Europe
Joined November 2011
📅 Get ready to make the most of EORTC’s upcoming events! Mark your calendars 👇 #CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26
0
2
15
🎉 What a day at #EORTC #PatientDays! Day 1 was packed with energy, empathy and honest round table talks. Thanks to all who joined, your voices are shaping the future of cancer care. 👋 See you tomorrow! 🔗 https://t.co/RaPPQ7Z44c
#CancerCare #PatientEngagement #Oncology
0
0
0
This November, the EORTC Cancer Research Fund is putting patients at the heart of research. From rare cancers to treatment optimisation, no patient is left behind. Learn more: https://t.co/VpWAserwXz
#LeavingNoCancerPatientBehind
0
0
1
🤝 EORTC #PatientDays kicks off today in Brussels! Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life. 🔗 Learn more: https://t.co/RaPPQ7ZBTK
#CancerResearch #Oncology #ClinicalTrials
0
1
2
👏 EORTC is proud to have hosted yesterday's meeting of the @EUonQol_ consortium. Thank you again to the Fondazione IRCCS Istituto Nazionale Tumori for organising this very productive meeting!💪 Looking forward to the next steps for EUonQOL. @IstTumori @EORTC_QLG #CancerResearch
The EUonQoL consortium gathered for a significant milestone in our journey to improve the way we assess quality of life. 💬 Hosted by the European Organisation for Research and Treatment of Cancer, the meeting focused on the project’s final outcome: the EUonQoL tool kit. 🔎
0
0
2
📢 New insights from PEACE-1 This post-hoc analysis examines how adjusting for abiraterone-prednisone cross-over impacts survival outcomes in de novo mCSPC. A key step in refining trial interpretation. 🔗Read more: https://t.co/pZ52AcbUrg
#PEACE1 #ProstateCancer
0
1
1
🎥 A highlight during #PinkOctober: Behind the scenes with the EORTC Breast Cancer Group. Watch the full video now 👉 For more info visit https://t.co/pJhfvgycAe
#BreastCancerAwarenessMonth #EORTCBreast #CancerResearch #ClinicalTrials #Oncology @BreastEuropean
0
1
4
📢 Abstract Submission deadline The call for abstracts for the 15th European Breast Cancer Conference (EBCC-15) in Barcelona is open until 3 November 2025. 👉 https://t.co/SXfvittmi5
#EBCC15 #BreastCancer #Oncology #bcsm
@OncoAlert @EORTC @EuropaDonnaEUR
0
4
4
📢New in Lung Cancer Journal! A pan-European panel led by the #EORTClung reviews 105 clinical cases to define resectable stage III NSCLC for trial inclusion. This consensus aims to improve patient selection and trial consistency across Europe. 🔗Read here: https://t.co/pZ52AcbUrg
0
0
2
📢 Join our team in #Brussels! The EORTC Projects and Services department is looking for a Project Manager. Do you have a master’s degree, a 5-year experience in a project management role and are you looking for a new challenge? 👉 Apply now: https://t.co/uxAjShZ7oA
#Jobs
0
0
2
📢 New publication alert! EORTC’s RENALUT trial explores [177Lu]Lu-PSMA-617 in metastatic ccRCC. The protocol summary is now out in @EurUrolOncol, highlighting radioligand therapy’s potential. 🔗 https://t.co/pZ52AcbUrg
#EORTC #RENALUT #ccRCC
1
0
0
👏 Today & tomorrow at #ISOQOL 2025, @EORTC #QualityofLife Group & colleagues will present 4 posters, exploring topics like ePRO implementation, side-effect burden measurement, & creating the PRO-AE inventory. 🔍 Learn more: https://t.co/xUmAq80xBH
@ISOQOL #GivingVoice2Patients
0
2
11
📣Exciting news! @EORTC, through its #QualityofLife (QoL) Group, is supporting #ISOQOL 2025 & will share insights into its latest QoL research through a series of impactful abstracts presented at the conference. Learn more👇 https://t.co/xUmAq80xBH
#GivingVoice2Patients @ISOQOL
0
1
8
🚨 LAST CHANCE! Today is the FINAL day to grab the early rate discount for #EBCC15 in Barcelona. Register now 👉 https://t.co/u2gWX1m007
@EuropaDonnaEUR @EORTC @OncoAlert
0
5
6
🙌 That’s a wrap on #ESMO25! EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation. Thanks to all collaborators and patients who make this work possible. 🔗 Full summary: https://t.co/zE9lVf4JKs
#CancerResearch
1
2
10
📢 Today is #WorldStatisticsDay, a moment to reflect on the tools that shape clinical research and medical progress. 👉 Do you feel p-values satisfy the needs of clinical research in summarizing proof? 🔗Read more: https://t.co/8pevfs2wm3
#ClinicalTrials #MedicalStatistics
0
0
1
👏 Congratulations to our @EORTC #QualityofLife Group members Veronika Engele & Louis Fox for their great presentations at #ESMO25. 🏅 And well done Veronika Engele for winning the ESMO 2025 Best Poster for Psycho-oncology! 💪 #CancerResearch #GivingVoice2Patients #EORTC
0
4
13
📢 Today we highlight a critical topic at #ESMO25: Eva Blondeaux presents on discontinuation and attrition in first-line RCTs for solid tumors. What do these trends mean for trial design and patient outcomes? Don't miss it! 🕥 10:45–10:50 #CancerResearch #EORTC
0
0
3
📢 Big news from EORTC! The PEACE III trial has reached its final overall survival results. Final analysis confirms that adding radium-223 to enzalutamide significantly improves survival in mCRPC patients. 👏 Huge thanks to all collaborators! 🔗 https://t.co/7F4xwaxCS8
0
3
4
CSO was at #ESMO2025 today, hosting a symposium to discuss our work in advancing patient-centred cancer care, and how best to engage colleagues and the broader community in Europe and beyond. #CommonSenseOncology
1
8
28
👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement! Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes. 📢 Don't miss it! #Oncology #PatientEngagement #EORTC
1
1
3